[1]
|
Effect of ALDH1A1 and CD44 on Survival and Disease Recurrence in Patients With Osteosarcoma
Cureus,
2024
DOI:10.7759/cureus.52404
|
|
|
[2]
|
Antioxidant 1 copper chaperone gene expression and copper levels in dog osteosarcoma patients
Veterinary and Comparative Oncology,
2023
DOI:10.1111/vco.12903
|
|
|
[3]
|
Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the HSP90A/NDRG1 pathway
Cellular Signalling,
2023
DOI:10.1016/j.cellsig.2023.110771
|
|
|
[4]
|
The Concept of Cancer Stem Cells: Elaborating on ALDH1B1 as an Emerging Marker of Cancer Progression
Life,
2023
DOI:10.3390/life13010197
|
|
|
[5]
|
Chondrosarcoma Resistance to Radiation Therapy: Origins and Potential Therapeutic Solutions
Cancers,
2023
DOI:10.3390/cancers15071962
|
|
|
[6]
|
Cancer Stem Cells in Sarcomas: In Vitro Isolation and Role as Prognostic Markers: A Systematic Review
Cancers,
2023
DOI:10.3390/cancers15092449
|
|
|
[7]
|
Cellular and Genetic Background of Osteosarcoma
Current Issues in Molecular Biology,
2023
DOI:10.3390/cimb45050276
|
|
|
[8]
|
Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the HSP90A/NDRG1 pathway
Cellular Signalling,
2023
DOI:10.1016/j.cellsig.2023.110771
|
|
|
[9]
|
Cancer Stem Cell Markers in Rhabdomyosarcoma in Children
Diagnostics,
2022
DOI:10.3390/diagnostics12081895
|
|
|
[10]
|
Morpholino-driven blockade of Dkk-1 in osteosarcoma inhibits bone damage and tumour expansion by multiple mechanisms
British Journal of Cancer,
2022
DOI:10.1038/s41416-022-01764-z
|
|
|
[11]
|
Quantitative proteomics analysis reveals novel insights into mechanisms of action of disulfiram (DSF)
PROTEOMICS – Clinical Applications,
2022
DOI:10.1002/prca.202100031
|
|
|
[12]
|
ALDH1A1 Gene Expression and Cellular Copper Levels between Low and Highly Metastatic Osteosarcoma Provide a Case for Novel Repurposing with Disulfiram and Copper
Sarcoma,
2022
DOI:10.1155/2022/7157507
|
|
|
[13]
|
Teaching new tricks to old dogs: A review of drug repositioning of disulfiram for cancer nanomedicine
VIEW,
2021
DOI:10.1002/VIW.20200127
|
|
|
[14]
|
Do Patient-derived Spheroid Culture Models Have Relevance in Chondrosarcoma Research?
Clinical Orthopaedics & Related Research,
2021
DOI:10.1097/CORR.0000000000001317
|
|
|
[15]
|
Update on Osteosarcoma
Current Oncology Reports,
2021
DOI:10.1007/s11912-021-01053-7
|
|
|
[16]
|
Cancer Stem Cells as a Source of Drug Resistance in Bone Sarcomas
Journal of Clinical Medicine,
2021
DOI:10.3390/jcm10122621
|
|
|
[17]
|
Do Patient-derived Spheroid Culture Models Have Relevance in Chondrosarcoma Research?
Clinical Orthopaedics & Related Research,
2021
DOI:10.1097/CORR.0000000000001317
|
|
|
[18]
|
Current Advances in the Science of Osteosarcoma
Advances in Experimental Medicine and Biology,
2020
DOI:10.1007/978-3-030-43085-6_10
|
|
|
[19]
|
Biological features of tissue and bone sarcomas investigated using an in vitro model of clonal selection
Pathology - Research and Practice,
2020
DOI:10.1016/j.prp.2020.153214
|
|
|
[20]
|
ALDH Expression in Angiosarcoma of the Lung: A Potential Marker of Aggressiveness?
Frontiers in Medicine,
2020
DOI:10.3389/fmed.2020.544158
|
|
|
[21]
|
TRAIL responses are enhanced by nuclear export inhibition in osteosarcoma
Biochemical and Biophysical Research Communications,
2019
DOI:10.1016/j.bbrc.2019.07.047
|
|
|
[22]
|
Combination Therapy with Disulfiram, Copper, and Doxorubicin for Osteosarcoma: In Vitro Support for a Novel Drug Repurposing Strategy
Sarcoma,
2019
DOI:10.1155/2019/1320201
|
|
|
[23]
|
Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents
Recent Patents on Anti-Cancer Drug Discovery,
2019
DOI:10.2174/1574892814666190514104035
|
|
|
[24]
|
Prospects for the involvement of cancer stem cells in the pathogenesis of osteosarcoma
Journal of Cellular Physiology,
2019
DOI:10.1002/jcp.29344
|
|
|
[25]
|
Cancer Stem Cells and Osteosarcoma
Techniques in Orthopaedics,
2019
DOI:10.1097/BTO.0000000000000408
|
|
|
[26]
|
Stem Cells Heterogeneity in Cancer
Advances in Experimental Medicine and Biology,
2019
DOI:10.1007/978-3-030-14366-4_11
|
|
|
[27]
|
Cancer Stem Cells and Osteosarcoma: Opportunities and Limitations
Techniques in Orthopaedics,
2019
DOI:10.1097/BTO.0000000000000408
|
|
|
[28]
|
A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas
Clinical Sarcoma Research,
2018
DOI:10.1186/s13569-018-0107-9
|
|
|
[29]
|
Disulfiram reduces metastatic osteosarcoma tumor burden in an immunocompetent Balb/c or-thotopic mouse model
Oncotarget,
2018
DOI:10.18632/oncotarget.25733
|
|
|
[30]
|
Novel molecular insights and new therapeutic strategies in osteosarcoma
Cancer Cell International,
2018
DOI:10.1186/s12935-018-0654-4
|
|
|
[31]
|
Pediatric sarcomas (Review)
Oncology Letters,
2017
DOI:10.3892/ol.2017.7467
|
|
|
[32]
|
Cancer stem cells in osteosarcoma
Cancer Letters,
2017
DOI:10.1016/j.canlet.2016.11.019
|
|
|
[33]
|
Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells
Cancer Chemotherapy and Pharmacology,
2017
DOI:10.1007/s00280-016-3213-5
|
|
|
[34]
|
Osteosarcoma - Biology, Behavior and Mechanisms
2017
DOI:10.5772/67627
|
|
|
[35]
|
Aldehyde dehydrogenase isoform 1 (ALDH1) expression as a predictor of radiosensitivity in laryngeal cancer
Clinical and Translational Oncology,
2016
DOI:10.1007/s12094-015-1445-1
|
|
|
[36]
|
Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors
Clinical & Experimental Metastasis,
2016
DOI:10.1007/s10585-015-9755-9
|
|
|
[37]
|
Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations
Scientific Reports,
2016
DOI:10.1038/srep27878
|
|
|
[38]
|
Lymph node metastasis of osteosarcomas
Arkhiv patologii,
2016
DOI:10.17116/patol201678458-62
|
|
|
[39]
|
Same difference: A pilot study of cyclin D1, bcl-2, AMACR, and ALDH-1 identifies significant differences in expression between primary colon adenocarcinoma and its metastases
Pathology - Research and Practice,
2016
DOI:10.1016/j.prp.2016.08.004
|
|
|
[40]
|
The Challenges of Detecting Circulating Tumor Cells in Sarcoma
Frontiers in Oncology,
2016
DOI:10.3389/fonc.2016.00202
|
|
|
[41]
|
Alcohol Dehydrogenases and Acetaldehyde Dehydrogenases are Beneficial for Decidual Stromal Cells to Resist the Damage from Alcohol
Alcohol and Alcoholism,
2016
DOI:10.1093/alcalc/agw073
|
|
|
[42]
|
Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations
Scientific Reports,
2016
DOI:10.1038/srep27878
|
|
|
[43]
|
Chondrosarcoma resection followed by a branched crural revascularization of the right calf: Case report
Cor et Vasa,
2016
DOI:10.1016/j.crvasa.2016.02.005
|
|
|
[44]
|
Chondrosarcoma resection followed by a branched crural revascularization of the right calf: Case report
Cor et Vasa,
2016
DOI:10.1016/j.crvasa.2016.02.005
|
|
|
[45]
|
Concise Review: Bullseye: Targeting Cancer Stem Cells to Improve the Treatment of Gliomas by Repurposing Disulfiram
Stem Cells,
2015
DOI:10.1002/stem.1956
|
|
|
[46]
|
Retinal Targets ALDH Positive Cancer Stem Cell and Alters the Phenotype of Highly Metastatic Osteosarcoma Cells
Sarcoma,
2015
DOI:10.1155/2015/784954
|
|
|
[47]
|
The HDAC Inhibitor Vorinostat Diminishes theIn VitroMetastatic Behavior of Osteosarcoma Cells
BioMed Research International,
2015
DOI:10.1155/2015/290368
|
|
|